Company Filing History:
Years Active: 2019-2020
Title: Innovations in Cancer Treatment by Xiaozhang Qian
Introduction
Xiaozhang Qian is a notable inventor based in Branford, CT (US). He has made significant contributions to the field of cancer treatment through his innovative approaches. With a total of two patents to his name, Qian's work focuses on combination therapies that utilize histone deacetylase (HDAC) inhibitors.
Latest Patents
Qian's latest patents revolve around methods for treating various types of cancer, including lung cancer, multiple myeloma, lymphoma, and epithelial ovarian cancer. His inventions involve the administration of a first amount or dose of an HDAC inhibitor, such as PXD-101, alongside a second amount or dose of another chemotherapeutic agent, like dexamethasone or 5-fluorouracil. Additionally, he explores the use of epidermal growth factor receptor (EGFR) inhibitors, such as Tarceva, to create a therapeutically effective treatment regimen.
Career Highlights
Xiaozhang Qian is currently associated with Topotarget UK Limited, where he continues to advance his research in cancer therapies. His work has the potential to significantly impact the treatment landscape for patients suffering from various cancers.
Collaborations
Qian collaborates with esteemed colleagues, including Henri Lichenstein and Mike Jeffers, to further enhance the effectiveness of his innovative treatments.
Conclusion
Xiaozhang Qian's contributions to cancer treatment through his patented methods highlight the importance of innovation in medical research. His work exemplifies the potential of combination therapies to improve patient outcomes in oncology.